Evidence map›Paper›PMID 31695778›Full record

ArticleTheranostics2019

Carcinoembryonic antigen carrying SLe

Catarina Gomes, Andreia Almeida, Ana Barreira, Juliana Calheiros, Filipe Pinto, Rafaela Abrantes, Ana Costa, António Polonia, Diana Campos, Hugo Osório and 4 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. CD15 Is a Risk Predictor and a Novel Target in Clear Cell Renal Cell Carcinoma.Pathobiology : journal of immunopathology, molecular and cellular biology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Sialyl LewisCancers · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Specific (sialyl-)Lewis core 2Theranostics · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Catarina GomesInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Andreia AlmeidaMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Ana BarreiraInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Juliana CalheirosInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Filipe PintoInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Rafaela AbrantesInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Ana CostaInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
António PoloniaInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Diana CamposInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Hugo OsórioInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Hugo SousaFaculty of Medicine, University of Porto, Porto, Portugal.
João Pinto-de-SousaInstitute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal.
Daniel KolarichMax Planck Institute of Colloids and Interfaces, Potsdam, Germany.
Celso A ReisInstituto de Investigação e Inovação em Saúde (I3S), Universidade do Porto, Porto, Portugal.
Universidade do Porto · PTi3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto · PTGriffith University · AUMax Planck Institute of Colloids and Interfaces · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant transformation of gastric cells is accompanied by the deregulated expression of glycosyltransferases leading to the biosynthesis of tumor-associated glycans such as the sialyl-Lewis X antigen (SLe

Indexed as

beta-Galactoside alpha-2,3-SialyltransferaseBiomarkers, TumorCarcinoembryonic AntigenCell Line, TumorGlycomicsGlycoproteinsHumansNeoplasm InvasivenessPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidasePrognosisSialyl Lewis X AntigenSialyltransferasesStomach NeoplasmsSurvival Analysisbeta-Galactoside alpha-2,3-SialyltransferaseBiomarkers, TumorCarcinoembryonic AntigenGlycoproteinsPeptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine AmidaseSialyl Lewis X AntigenSialyltransferasesST3GAL1 protein, humanCarcinoembryonic antigenGastric CancerGlycosylationSialyl-Lewis XST3Gal IV

Identifiers

PMID31695778
PMCPMC6831293
OpenAlexW2982023950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.